• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Joseph Alvarnas Joins as Editor-in-Chief of Evidence-Based Oncology

Video

Evidence-Based Oncology is an important forum to have conversations that are needed in medicine today, said Joseph Alvarnas, MD, the new editor-in-chief of the journal.

Evidence-Based Oncology is an important forum to have conversations that are needed in medicine today, said Joseph Alvarnas, MD, the new editor-in-chief of the journal.

Physicians, nurses, payers, health systems, economists, and others have all existed in their own realms, he explained.

"The only to make the system work in ways which add value to our experience of care and care delivery is for us to break out of these silos and have honest conversations," Dr Alvarnas said.

See the latest issue of Evidence-Based Oncology here.

Related Videos
Joshua K. Sabari, MD
Nicoletta Colombo, MD, PhD
Khush Kharidia, MD
Jo Varshney, PhD, DVM, CEO and founder, VeriSIM Life
Kimberly Westrich, MA, chief strategy officer, National Pharmaceutical Council
Harry Travis, BS Pharm, MBA, president at The Travis Group, LLC
Brigid Groves, PharmD, MS, vice president, professional affairs, American Pharmacists Association
Chelsea Renfro, PharmD, research and engagement pharmacist, Vanderbilt Specialty Pharmacy
Marc S. Raab, MD, PhD, University Hospital Heidelberg
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Related Content
Lisa Taylor-Swanson, PhD

Culturally Competent Menopause Care: Lisa Taylor-Swanson, PhD

October 31st 2025
Article

Lisa Taylor-Swanson, PhD, explains how including Indigenous and Hispanic women in conversations around menopause care helps fine-tune interventions.

Read More

Age-Related Disparities in ADC Treatment Rates in Breast Cancer with Tabby Khan, MD

Age-Related Disparities in ADC Treatment Rates in Breast Cancer with Tabby Khan, MD

October 31st 2025
Podcast

A new analysis from Komodo Health pinpointed significant disparities by age and insurance in antibody-drug conjugate (ADC) treatment rates for metastatic breast cancer.

Listen

Emma Guttman-Yassky, MD, PhD | Image Credit: © Icahn School of Medicine at Mount Sinai

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

October 30th 2025
Article

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

October 30th 2025
Podcast

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

Cate Lockhart, PharmD, PhD

Real-World Evidence Standards Bridge Research, Clinical Decision-Making: Cate Lockhart, PharmD, PhD

October 29th 2025
Article

Real-world evidence helps pharmaceutical companies and payers communicate more effectively.

Read More

The report offers strong evidence affirming previous reports suggesting that people with obesity may be at a heightened risk of DLBCL. | Image Credit: zhuan - stock.adobe.com

Genetic Obesity Linked With DLBCL Risk

October 28th 2025
Article

New reporting suggests obesity and diffuse large B-cell lymphoma (DLBCL) have shared genetic risk factors.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.